Milestone Scientific Reveals Launch of New Instrument for Botox Delivery


 
 
11:33 11/20/2017

A leading developer of drug delivery equipment that distributes accurate and painless injections, Milestone Scientific Inc. MLSS , announced a new cosmetic injection instrument for delivery of botulinum toxin (Botox and Dysport).

The main elements of the new instrument includes an improved needle placement with a comfortable grip and an electronic motor to get the doses correctly for each use. It also has a touch-screen interface that is simple and efficient to operate.

Milestone Scientific MLSS  is one of the top leading medical research and development company that practices patent innovations. Chairman and Interim CEO, Leslie Bernhard said, “There is a large and growing market for botulinum toxin (such as Botox and Dysport) injections globally, with over 8.4 million botulinum toxin injections annually in the U.S alone.”

“Recognizing this opportunity, we set out to develop a product concept and conducted a cosmetic injection instrument feasibility study to determine professional interest in a new cosmetic injection system,” Bernhard added.

Other major highlights included in this new innovative product includes a wireless ability with high-capacity battery lasting for hours on end. Also, everything is electronically recorded when the instrument is in use and logs data into its medical record system.

While manufacturing this new instrument, Milestone Scientific MLSS  completed a series of human studies with targeted customers while using the new product. Based on the positive results, they plan to move forward aggressively towards the launch of the cosmetic instrument, releasing first in Europe.

After a couple trial runs and tests in Europe with the official launch, Milestone plans to launch the product in the U.S and all throughout Asia.


This article has been provided by a Chasing Markets contributor. All content submitted by this author represent their personal opinions, and should be considered as such for entertainment purpose only. All opinions expressed are those of the writer, and may not necessarily represent fact, opinions, or bias of Chasing Markets.
Most Read